Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model

Brian D. Piccolo, James L. Graham, Kimber Stanhope, Oliver Fiehn, Peter J Havel, Sean H. Adams

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Elevations of plasma concentrations of branched-chain amino acids (BCAAs) are observed in human insulin resistance and type 2 diabetes mellitus (T2DM); however, there has been some controversy with respect to the passive or causative nature of the BCAA phenotype. Using untargeted metabolomics, plasma BCAA and other metabolites were assessed in lean control Sprague-Dawley rats (LC) and temporally during diabetes development in the UCD-T2DM rat model, i.e., prediabetic (PD) and 2 wk (D2W), 3 mo (D3M), and 6 mo (D6M) post-onset of diabetes. Plasma leucine, isoleucine, and valine concentrations were elevated only in D6M rats compared with D2W rats (by 28, 29, and 30%, respectively). This was in contrast to decreased plasma concentrations of several other amino acids in D3M and/or D6M relative to LC rats (Ala, Arg, Glu, Gln, Met, Ser, Thr, and Trp). BCAAs were positively correlated with fasting glucose and negatively correlated with plasma insulin, total body weight, total adipose tissue weight, and gastrocnemius muscle weight in the D3M and D6M groups. Multivariate analysis revealed that D3M and D6M UCD-T2DM rats had lower concentrations of amino acids, amino acid derivatives, 1,5-anhydroglucitol, and conduritol-β-opoxide and higher concentrations of uronic acids, pantothenic acids, aconitate, benzoic acid, lactate, and monopalmitin-2-glyceride relative to PD and D2W UCDT2DM rats. The UCD-T2DM rat does not display elevated plasma BCAA concentrations until 6 mo post-onset of diabetes. With the acknowledgement that this is a rodent model of T2DM, the results indicate that elevated plasma BCAA concentrations are not necessary or sufficient to elicit an insulin resistance or T2DM onset.

Original languageEnglish (US)
Pages (from-to)E958-E969
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume310
Issue number11
DOIs
StatePublished - Jun 1 2016

Fingerprint

Branched Chain Amino Acids
Type 2 Diabetes Mellitus
Amino Acids
Insulin Resistance
Aconitic Acid
Pantothenic Acid
Uronic Acids
Glycerides
Weights and Measures
Benzoic Acid
Metabolomics
Isoleucine
Valine
Leucine
Sprague Dawley Rats
Adipose Tissue
Rodentia
Lactic Acid
Fasting
Skeletal Muscle

Keywords

  • Amino acids
  • Branched-chain amino acids
  • Branched-chain amino aicds
  • Diabetes
  • University of California at Davis type 2 diabetes rat model

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Medicine(all)
  • Physiology (medical)

Cite this

Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model. / Piccolo, Brian D.; Graham, James L.; Stanhope, Kimber; Fiehn, Oliver; Havel, Peter J; Adams, Sean H.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 310, No. 11, 01.06.2016, p. E958-E969.

Research output: Contribution to journalArticle

Piccolo, Brian D. ; Graham, James L. ; Stanhope, Kimber ; Fiehn, Oliver ; Havel, Peter J ; Adams, Sean H. / Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model. In: American Journal of Physiology - Endocrinology and Metabolism. 2016 ; Vol. 310, No. 11. pp. E958-E969.
@article{a690dd582da14a55b93769ed1b640864,
title = "Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model",
abstract = "Elevations of plasma concentrations of branched-chain amino acids (BCAAs) are observed in human insulin resistance and type 2 diabetes mellitus (T2DM); however, there has been some controversy with respect to the passive or causative nature of the BCAA phenotype. Using untargeted metabolomics, plasma BCAA and other metabolites were assessed in lean control Sprague-Dawley rats (LC) and temporally during diabetes development in the UCD-T2DM rat model, i.e., prediabetic (PD) and 2 wk (D2W), 3 mo (D3M), and 6 mo (D6M) post-onset of diabetes. Plasma leucine, isoleucine, and valine concentrations were elevated only in D6M rats compared with D2W rats (by 28, 29, and 30{\%}, respectively). This was in contrast to decreased plasma concentrations of several other amino acids in D3M and/or D6M relative to LC rats (Ala, Arg, Glu, Gln, Met, Ser, Thr, and Trp). BCAAs were positively correlated with fasting glucose and negatively correlated with plasma insulin, total body weight, total adipose tissue weight, and gastrocnemius muscle weight in the D3M and D6M groups. Multivariate analysis revealed that D3M and D6M UCD-T2DM rats had lower concentrations of amino acids, amino acid derivatives, 1,5-anhydroglucitol, and conduritol-β-opoxide and higher concentrations of uronic acids, pantothenic acids, aconitate, benzoic acid, lactate, and monopalmitin-2-glyceride relative to PD and D2W UCDT2DM rats. The UCD-T2DM rat does not display elevated plasma BCAA concentrations until 6 mo post-onset of diabetes. With the acknowledgement that this is a rodent model of T2DM, the results indicate that elevated plasma BCAA concentrations are not necessary or sufficient to elicit an insulin resistance or T2DM onset.",
keywords = "Amino acids, Branched-chain amino acids, Branched-chain amino aicds, Diabetes, University of California at Davis type 2 diabetes rat model",
author = "Piccolo, {Brian D.} and Graham, {James L.} and Kimber Stanhope and Oliver Fiehn and Havel, {Peter J} and Adams, {Sean H.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1152/ajpendo.00052.2016",
language = "English (US)",
volume = "310",
pages = "E958--E969",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "11",

}

TY - JOUR

T1 - Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model

AU - Piccolo, Brian D.

AU - Graham, James L.

AU - Stanhope, Kimber

AU - Fiehn, Oliver

AU - Havel, Peter J

AU - Adams, Sean H.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Elevations of plasma concentrations of branched-chain amino acids (BCAAs) are observed in human insulin resistance and type 2 diabetes mellitus (T2DM); however, there has been some controversy with respect to the passive or causative nature of the BCAA phenotype. Using untargeted metabolomics, plasma BCAA and other metabolites were assessed in lean control Sprague-Dawley rats (LC) and temporally during diabetes development in the UCD-T2DM rat model, i.e., prediabetic (PD) and 2 wk (D2W), 3 mo (D3M), and 6 mo (D6M) post-onset of diabetes. Plasma leucine, isoleucine, and valine concentrations were elevated only in D6M rats compared with D2W rats (by 28, 29, and 30%, respectively). This was in contrast to decreased plasma concentrations of several other amino acids in D3M and/or D6M relative to LC rats (Ala, Arg, Glu, Gln, Met, Ser, Thr, and Trp). BCAAs were positively correlated with fasting glucose and negatively correlated with plasma insulin, total body weight, total adipose tissue weight, and gastrocnemius muscle weight in the D3M and D6M groups. Multivariate analysis revealed that D3M and D6M UCD-T2DM rats had lower concentrations of amino acids, amino acid derivatives, 1,5-anhydroglucitol, and conduritol-β-opoxide and higher concentrations of uronic acids, pantothenic acids, aconitate, benzoic acid, lactate, and monopalmitin-2-glyceride relative to PD and D2W UCDT2DM rats. The UCD-T2DM rat does not display elevated plasma BCAA concentrations until 6 mo post-onset of diabetes. With the acknowledgement that this is a rodent model of T2DM, the results indicate that elevated plasma BCAA concentrations are not necessary or sufficient to elicit an insulin resistance or T2DM onset.

AB - Elevations of plasma concentrations of branched-chain amino acids (BCAAs) are observed in human insulin resistance and type 2 diabetes mellitus (T2DM); however, there has been some controversy with respect to the passive or causative nature of the BCAA phenotype. Using untargeted metabolomics, plasma BCAA and other metabolites were assessed in lean control Sprague-Dawley rats (LC) and temporally during diabetes development in the UCD-T2DM rat model, i.e., prediabetic (PD) and 2 wk (D2W), 3 mo (D3M), and 6 mo (D6M) post-onset of diabetes. Plasma leucine, isoleucine, and valine concentrations were elevated only in D6M rats compared with D2W rats (by 28, 29, and 30%, respectively). This was in contrast to decreased plasma concentrations of several other amino acids in D3M and/or D6M relative to LC rats (Ala, Arg, Glu, Gln, Met, Ser, Thr, and Trp). BCAAs were positively correlated with fasting glucose and negatively correlated with plasma insulin, total body weight, total adipose tissue weight, and gastrocnemius muscle weight in the D3M and D6M groups. Multivariate analysis revealed that D3M and D6M UCD-T2DM rats had lower concentrations of amino acids, amino acid derivatives, 1,5-anhydroglucitol, and conduritol-β-opoxide and higher concentrations of uronic acids, pantothenic acids, aconitate, benzoic acid, lactate, and monopalmitin-2-glyceride relative to PD and D2W UCDT2DM rats. The UCD-T2DM rat does not display elevated plasma BCAA concentrations until 6 mo post-onset of diabetes. With the acknowledgement that this is a rodent model of T2DM, the results indicate that elevated plasma BCAA concentrations are not necessary or sufficient to elicit an insulin resistance or T2DM onset.

KW - Amino acids

KW - Branched-chain amino acids

KW - Branched-chain amino aicds

KW - Diabetes

KW - University of California at Davis type 2 diabetes rat model

UR - http://www.scopus.com/inward/record.url?scp=84977557735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977557735&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00052.2016

DO - 10.1152/ajpendo.00052.2016

M3 - Article

C2 - 27094034

AN - SCOPUS:84977557735

VL - 310

SP - E958-E969

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 11

ER -